AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

RHYTHM BIOSCIENCES LTD

0.205

0.000

Volume:- -

Turnover:- -

Market Cap:66.84M

PE:-9.22

High:0.205

Open:0.205

Low:0.205

Close:0.205

52wk High:0.280

52wk Low:0.047

Shares:326.07M

Float Shares:188.31M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.022

EPS(LYR):-0.014

ROE:-190.14%

ROA:-91.40%

PB:31.19

PE(LYR):-14.41

Loading ...

Overview Company News Filings

BRIEF-Rhythm Biosciences Seeks Trading Halt

Rhythm Biosciences Signs Distribution Deal With Pathology Company; Shares Up 10%

MT Newswires Live

BRIEF-Rhythm Biosciences Enters ColoSTAT Services Agreement With 4Cyte Pathology

Rhythm Biosciences Ltd - Enters Colostat Services Agreement With 4Cyte Pathology

THOMSON REUTERS

Rhythm Biosciences Enrolls First Physician Participant in Colorectal Cancer Detection Test Program; Shares Jump 9%

MT Newswires Live

BUZZ-Rhythm Biosciences set for best week in nearly 6 years

The 38% return this week takes Rhythm Biosciences' (ASX:RHY) shareholders one-year gains to 167%

Simply Wall St.

Rhythm Biosciences Secures Manufacturing Agreement With US-Based Manufacturer for Cancer Blood Test Product

MT Newswires Live

BUZZ-Australia's Rhythm Biosciences at nearly 6-month high on multi-year supply agreement

BRIEF-Rhythm Biosciences Signs Manufacturing Agreement

Rhythm Biosciences - Multi-Year Commercial Supply Agreement Executed With Quansys Biosciences for Colostat Re- Agent Kit Manufacturing

THOMSON REUTERS

BUZZ-Rhythm Biosciences gains on Australian Genome Research Facility partnership

Rhythm Biosciences Biosciences Secures Strategic Alliance With AGRF

Rhythm Biosciences Ltd - Partnership to Accelerate Commercial Scale-up of Genetype Service

THOMSON REUTERS

Rhythm Biosciences Ltd - Rhythm Biosciences Secures Strategic Alliance With Agrf

THOMSON REUTERS

BRIEF-Rhythm Biosciences Secures Strategic Us Partnership With Cancer IQ

Rhythm Biosciences Ltd - Secures Strategic US Partnership With Cancer Iq

THOMSON REUTERS

Enhanced Genetype colorectal cancer risk test released - supports earlier disease detection and ColoSTAT® targeting

Rhythm Biosciences Partners with datma to Advance Genomic Cancer Diagnostics

Datma and Rhythm Biosciences Announce Collaboration to Apply Federated Real-World Data to Genomic Diagnostic Development

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RHY.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RHY.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RHY.AU\",,,,,undefined,":{"symbol":"RHY.AU","market":"AU","secType":"STK","nameCN":"RHYTHM BIOSCIENCES LTD","latestPrice":0.205,"timestamp":1771823520000,"preClose":0.205,"halted":0,"volume":0,"delay":0,"changeRate":0,"nameEN":"RHYTHM BIOSCIENCES LTD","floatShares":188306561,"shares":326068419,"eps":-0.022243,"marketStatus":"Closed","change":0,"latestTime":"02-23 16:12:00 AEDT","open":0.205,"high":0.205,"low":0.205,"amount":0,"amplitude":0,"askPrice":0.205,"askSize":2222,"bidPrice":0.225,"bidSize":100000,"shortable":3,"etf":0,"ttmEps":-0.022243,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1771887600000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.205,"openAndCloseTimeList":[[1771801200000,1771822800000]],"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RHY.AU\",,,,,undefined,":{"symbol":"RHY.AU","floatShares":188306561,"roa":"-91.40%","roe":"-190.14%","lyrEps":-0.014222,"shares":326068419,"dividePrice":0,"high":0.205,"amplitude":0,"preClose":0.205,"low":0.205,"week52Low":0.047,"pbRate":"31.19","psRate":"40.57","week52High":0.28,"institutionHeld":0,"latestPrice":0.205,"committee":0.956526,"eps":-0.022243,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.022243,"open":0.205,"prevYearClose":0.135,"prevWeekClose":0.205,"prevMonthClose":0.145,"prevQuarterClose":0.135,"fiveDayClose":0.205,"twentyDayClose":0.15,"sixtyDayClose":0.09,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RHY.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2020-07-27","symbol":"RHY.AU","type":"split","dateTimestamp":1595772000000,"forFactor":875,"toFactor":1000,"ratio":0.875}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RHY.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RHY.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2613274488","title":"BRIEF-Rhythm Biosciences Seeks Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2613274488","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613274488?lang=en_us&edition=fundamental","pubTime":"2026-02-23 06:56","pubTimestamp":1771800998,"startTime":"0","endTime":"0","summary":"BRIEF-Rhythm Biosciences Seeks Trading Halt Feb 23 (Reuters) - Rhythm Biosciences Ltd RHY.AX:SEEKS TRADING HALT PENDING UNDERWRITING AGREEMENT ANNOUNCEMENTFurther company coverage: RHY.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260222:nFWN3ZG0TS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7124","RHY.AU"],"gpt_icon":0},{"id":"2612943981","title":"Rhythm Biosciences Signs Distribution Deal With Pathology Company; Shares Up 10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612943981","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612943981?lang=en_us&edition=fundamental","pubTime":"2026-02-17 10:50","pubTimestamp":1771296649,"startTime":"0","endTime":"0","summary":"Rhythm Biosciences  entered into a distribution service agreement with 4Cyte Pathology for its ColoSTAT diagnostic test for the detection of colorectal cancer, according to a Tuesday filing with the Australian bourse.4Cyte will integrate ColoSTAT into its clinical ordering system across its network of patient collection centers in New South Wales, Victoria, and Queensland, with no minimum volume commitments or upfront payments under the deal, the filing said.The deal has an initial three-year term and an option for a two-year extension by mutual agreement, per the filing.Rhythm Biosciences shares rose nearly 10% in afternoon trade on Tuesday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RHY.AU","BK7124"],"gpt_icon":0},{"id":"2612884438","title":"BRIEF-Rhythm Biosciences Enters ColoSTAT Services Agreement With 4Cyte Pathology","url":"https://stock-news.laohu8.com/highlight/detail?id=2612884438","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612884438?lang=en_us&edition=fundamental","pubTime":"2026-02-17 06:21","pubTimestamp":1771280464,"startTime":"0","endTime":"0","summary":"BRIEF-Rhythm Biosciences Enters ColoSTAT Services Agreement With 4Cyte PathologyFeb 17 (Reuters) - Rhythm Biosciences Ltd RHY.AX:ENTERS COLOSTAT SERVICES AGREEMENT WITH 4CYTE PATHOLOGYFurther company coverage: RHY.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260216:nFWN3ZC0GZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RHY.AU","BK7124"],"gpt_icon":0},{"id":"2612696480","title":"Rhythm Biosciences Ltd -  Enters Colostat Services Agreement With 4Cyte Pathology","url":"https://stock-news.laohu8.com/highlight/detail?id=2612696480","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612696480?lang=en_us&edition=fundamental","pubTime":"2026-02-17 05:39","pubTimestamp":1771277998,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260216:nFWN3ZC0GZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7124","RHY.AU"],"gpt_icon":0},{"id":"2610606565","title":"Rhythm Biosciences Enrolls First Physician Participant in Colorectal Cancer Detection Test Program; Shares Jump 9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610606565","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610606565?lang=en_us&edition=fundamental","pubTime":"2026-02-11 10:03","pubTimestamp":1770775389,"startTime":"0","endTime":"0","summary":"Rhythm Biosciences  enrolled the first physician participant in its ColoSTAT Access Program, a commercial deployment framework for its blood-based test for the detection of colorectal cancer, according to a Wednesday Australian bourse filing.Under the program, participating clinicians receive an initial allocation of ColoSTAT tests at no cost and continued use of the test after the initial allocation is expected to be on a paid basis, the filing said. The program will be capped at 20 participants in Australia.Rhythm Biosciences' shares jumped nearly 9% in recent trading on Wednesday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7124","RHY.AU"],"gpt_icon":0},{"id":"2609290553","title":"BUZZ-Rhythm Biosciences set for best week in nearly 6 years","url":"https://stock-news.laohu8.com/highlight/detail?id=2609290553","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609290553?lang=en_us&edition=fundamental","pubTime":"2026-02-06 12:51","pubTimestamp":1770353471,"startTime":"0","endTime":"0","summary":"BUZZ-Rhythm Biosciences set for best week in nearly 6 years** Shares of Australia's Biosciences RHY.AX rise as much as 19.2% to A$0.28, their highest level since October 11, 2023** On track for best week since late-March 2020, gaining 79.3% this week** The medical diagnostics tech firm secured a multi-year commercial supply agreement executed with U.S.-based Quansys Biosciences for ColoSTAT reagent kit manufacturing on Tuesday** About 3.1 million shares change hands, 3.4 times the 30-day avg** Up 92.6% YTD  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nL6N3Z20AY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7124","RHY.AU"],"gpt_icon":0},{"id":"2609153073","title":"The 38% return this week takes Rhythm Biosciences' (ASX:RHY) shareholders one-year gains to 167%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609153073","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609153073?lang=en_us&edition=fundamental","pubTime":"2026-02-06 07:16","pubTimestamp":1770333403,"startTime":"0","endTime":"0","summary":"Unless you borrow money to invest, the potential losses are limited. On the other hand, if you find a high quality...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-rhy/rhythm-biosciences-shares/news/the-38-return-this-week-takes-rhythm-biosciences-asxrhy-shar","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-rhy/rhythm-biosciences-shares/news/the-38-return-this-week-takes-rhythm-biosciences-asxrhy-shar","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["RHY.AU","BK7124"],"gpt_icon":0},{"id":"2608479418","title":"Rhythm Biosciences Secures Manufacturing Agreement With US-Based Manufacturer for Cancer Blood Test Product","url":"https://stock-news.laohu8.com/highlight/detail?id=2608479418","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608479418?lang=en_us&edition=fundamental","pubTime":"2026-02-03 15:06","pubTimestamp":1770102389,"startTime":"0","endTime":"0","summary":"Rhythm Biosciences  has executed a multi-year commercial supply agreement with Quansys Biosciences, a US-based manufacturer, to produce ColoSTAT reagent kits, the company's blood test product for cancer, according to a Tuesday Australian bourse filing.The company said that the agreement provides scalable manufacturing capacity to support the ColoSTAT Access Program and commercial rollout and includes provisions for minimum order volumes and a pricing framework to support anticipated operational requirements.The company added that the supply partnership reduces manufacturing scale-up and quality system risk following two years of successful assay development collaboration.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7124","RHY.AU"],"gpt_icon":0},{"id":"2608281217","title":"BUZZ-Australia's Rhythm Biosciences at nearly 6-month high on multi-year supply agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2608281217","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608281217?lang=en_us&edition=fundamental","pubTime":"2026-02-03 09:33","pubTimestamp":1770082415,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Rhythm Biosciences at nearly 6-month high on multi-year supply agreement** Shares of Rhythm Biosciences RHY.AX rise as much as 33.3% to A$0.20, their highest level since August 6, 2025** The medical diagnostics tech firm secures a multi-year commercial supply agreement executed with U.S.-based Quansys Biosciences for ColoSTAT reagent kit manufacturing** Agreement provides scalable manufacturing capacity to support ColoSTAT Access Program and commercial rollout, adds co** About 1.5 million shares change hands, 2.3x the 30-day average** YTD, stock up 37% year, including the day's move  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nL4N3YZ039:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RHY.AU","BK7124"],"gpt_icon":0},{"id":"2608814042","title":"BRIEF-Rhythm Biosciences Signs Manufacturing Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2608814042","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608814042?lang=en_us&edition=fundamental","pubTime":"2026-02-03 09:17","pubTimestamp":1770081464,"startTime":"0","endTime":"0","summary":"BRIEF-Rhythm Biosciences Signs Manufacturing AgreementFeb 3 (Reuters) - Rhythm Biosciences Ltd RHY.AX:RHYTHM BIOSCIENCES SIGNS MANUFACTURING AGREEMENTMULTI-YEAR COMMERCIAL SUPPLY AGREEMENT EXECUTED WI","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nFWN3YY1P5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RHY.AU","BK7124"],"gpt_icon":0},{"id":"2608818753","title":"Rhythm Biosciences - Multi-Year Commercial Supply Agreement Executed With Quansys Biosciences for Colostat Re- Agent Kit Manufacturing","url":"https://stock-news.laohu8.com/highlight/detail?id=2608818753","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608818753?lang=en_us&edition=fundamental","pubTime":"2026-02-03 05:45","pubTimestamp":1770068717,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nFWN3YY1P5:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7124","RHY.AU"],"gpt_icon":0},{"id":"2607771970","title":"BUZZ-Rhythm Biosciences gains on Australian Genome Research Facility partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2607771970","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607771970?lang=en_us&edition=fundamental","pubTime":"2026-01-29 12:21","pubTimestamp":1769660504,"startTime":"0","endTime":"0","summary":"BUZZ-Rhythm Biosciences gains on Australian Genome Research Facility partnership** Shares of Australia's Rhythm Biosciences RHY.AX rise as much as 16.7% to A$0.175, their highest level since January 16. ** Medical diagnostics tech firm announces strategic partnership with Australian Genome Research Facility. ** Partnership to establish commercial-scale processing capability for its predictive diagnostic tests platform, geneType, clinical services** About 2.2 million shares traded so far, 2.6x the 30-day avg** Stock up 22% in January so far, including the session's move","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nL6N3YU08W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RHY.AU","BK7124"],"gpt_icon":0},{"id":"2607778822","title":"Rhythm Biosciences Biosciences Secures Strategic Alliance With AGRF","url":"https://stock-news.laohu8.com/highlight/detail?id=2607778822","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607778822?lang=en_us&edition=fundamental","pubTime":"2026-01-29 09:42","pubTimestamp":1769650978,"startTime":"0","endTime":"0","summary":"Jan 29 (Reuters) - Rhythm Biosciences Ltd ::*RHYTHM BIOSCIENCES SECURES STRATEGIC ALLIANCE WITH AGRF*PARTNERSHIP TO ACCELERATE COMMERCIAL SCALE-UP OF GENETYPE SERVICE*Further company coverage: RHY.AX*","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nRSDbk2JCB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7124","RHY.AU"],"gpt_icon":0},{"id":"2607725773","title":"Rhythm Biosciences Ltd - Partnership to Accelerate Commercial Scale-up of Genetype Service","url":"https://stock-news.laohu8.com/highlight/detail?id=2607725773","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607725773?lang=en_us&edition=fundamental","pubTime":"2026-01-29 06:09","pubTimestamp":1769638193,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nFWN3YT16P:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7124","RHY.AU"],"gpt_icon":0},{"id":"2607224725","title":"Rhythm Biosciences Ltd - Rhythm Biosciences Secures Strategic Alliance With Agrf","url":"https://stock-news.laohu8.com/highlight/detail?id=2607224725","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607224725?lang=en_us&edition=fundamental","pubTime":"2026-01-29 06:09","pubTimestamp":1769638193,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nFWN3YT16P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RHY.AU","BK7124"],"gpt_icon":0},{"id":"2606575721","title":"BRIEF-Rhythm Biosciences Secures Strategic Us Partnership With Cancer IQ","url":"https://stock-news.laohu8.com/highlight/detail?id=2606575721","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606575721?lang=en_us&edition=fundamental","pubTime":"2026-01-28 09:37","pubTimestamp":1769564221,"startTime":"0","endTime":"0","summary":"BRIEF-Rhythm Biosciences Secures Strategic Us Partnership With Cancer IQJan 28 (Reuters) - Rhythm Biosciences Ltd RHY.AX:SECURES STRATEGIC US PARTNERSHIP WITH CANCER IQFurther company coverage: RHY.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nFWN3YS1B9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7124","RHY.AU"],"gpt_icon":0},{"id":"2606755021","title":"Rhythm Biosciences Ltd - Secures Strategic US Partnership With Cancer Iq","url":"https://stock-news.laohu8.com/highlight/detail?id=2606755021","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606755021?lang=en_us&edition=fundamental","pubTime":"2026-01-28 06:23","pubTimestamp":1769552614,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260127:nFWN3YS1B9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7124","RHY.AU"],"gpt_icon":0},{"id":"2603665390","title":"Enhanced Genetype colorectal cancer risk test released - supports earlier disease detection and ColoSTAT® targeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2603665390","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603665390?lang=en_us&edition=fundamental","pubTime":"2026-01-14 11:40","pubTimestamp":1768362000,"startTime":"0","endTime":"0","summary":"MELBOURNE, Australia, Jan. 14, 2026 /PRNewswire/ --Rhythm Biosciences Ltd  , a transformative, predictive cancer diagnostics technology company is pleased to announce the commercial launch of its updated geneTypeTM Colorectal Cancer  Risk Assessment clinical test , a significant advancement in personalised cancer risk prediction. The updated test incorporates additional clinical and lifestyle risk factors alongside the established 140-SNP polygenic risk score , delivering improved predictive accuracy across both genders and a wider age range.The enhanced test is designed to support earlier identification of individuals at elevated risk of colorectal cancer, enabling more targeted screening pathways and complementing Rhythm's ColoSTAT blood-based CRC detection test.Validation data for the updated model has been recently published in the peer-reviewed journal PLOS ONE , demonstrating improved predictive performance compared to traditional approaches.Rhythm Biosciences Ltd  is an Australi","market":"sg","thumbnail":"https://mma.prnewswire.com/media/2861328/Rhythm_Biosciences_Vert_CMYK_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2861328/Rhythm_Biosciences_Vert_CMYK_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/enhanced-genetype-colorectal-cancer-risk-test-released--supports-earlier-disease-detection-and-colostat-targeting-302660578.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7124","LU0266512127.USD","RHY.AU","BK4213","CRC","PRS","LU0456854461.SGD"],"gpt_icon":0},{"id":"2593480808","title":"Rhythm Biosciences Partners with datma to Advance Genomic Cancer Diagnostics","url":"https://stock-news.laohu8.com/highlight/detail?id=2593480808","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593480808?lang=en_us&edition=fundamental","pubTime":"2025-12-22 21:04","pubTimestamp":1766408679,"startTime":"0","endTime":"0","summary":"Rhythm Biosciences Ltd. has announced an exploratory collaboration with datma, a leader in federated real-world data access, to evaluate how datma's federated data platform, datma.FED, can support and accelerate the commercialization of Rhythm's genomic-integrated cancer risk prediction portfolio. The partnership will focus on leveraging longitudinal, de-identified real-world clinical data to aid in the development of Rhythm's geneType risk assessment tool, supporting clinical utility evidence generation and health economic modelling. This collaboration aims to enhance the clinical relevance and adoption of population-based cancer risk stratification tools.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rhythm Biosciences Ltd. publishe","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nNDLbq9mfr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RHY.AU","BK7124"],"gpt_icon":0},{"id":"2593487705","title":"Datma and Rhythm Biosciences Announce Collaboration to Apply Federated Real-World Data to Genomic Diagnostic Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2593487705","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593487705?lang=en_us&edition=fundamental","pubTime":"2025-12-22 21:00","pubTimestamp":1766408404,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nTUAJ1LWC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RHY.AU","BK7124"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":37,"code":"91000000","status":"200"}]}}